Circulation, Vol 72, 708-712, Copyright © 1985 by American Heart Association
RR Gorman, TD Oglesby, GL Bundy and NK Hopkins
Incubation of cultured human umbilical vein endothelial cells with [1-
14C]-arachidonic acid, followed by RP-HPLC analysis, resulted in the
appearance of two principal radioactive products besides 6-keto-PGF1 alpha.
The first peak was HHT, a hydrolysis product of the prostaglandin
endoperoxide. The second peak was esterified, converted to the
trimethylsilyl ether derivative, and analyzed by GC/MS and was shown to be
the lipoxygenase product 15-HETE. Stimulation of endothelial cells with
thrombin enhanced 15-HETE synthesis from arachidonate. Subsequent
experiments showed that 5-HETE and 12-HETE were also synthesized by
endothelial cells, but no evidence of leukotriene synthesis was found.
Incubation of the 15-HETE precursor 15- HPETE with endothelial cells
resulted in the formation of four distinct ultraviolet light-absorbing
peaks. Ultraviolet and GC/MS analysis showed these peaks to be 8,15-diHETEs
that differed only in their hydroxyl configuration and cis-trans
double-bond geometry. Formation of 8,15-diHETE molecules suggests the prior
formation of the unstable epoxide molecule 14,15-LTA4 or an attack at C-10
of 15-HPETE by an enzyme with mechanistic features in common with a
12-lipoxygenase. The observation that endothelial cells can synthesize both
15-HETE and 8,15- diHETE molecules suggest that this cell type contains
both a 15- lipoxygenase and a system that can synthesize 14,15-LTA4.
ARTICLES
Evidence for 15-HETE synthesis by human umbilical vein endothelial cells
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1985 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |